
336: Pharma's big patent cliff, more obesity fundraising, and a failed ALS study
The Readout Loud
00:00
Intro
This chapter covers the upcoming JPM week and its effects on biotech deal-making amidst a looming patent cliff. It also discusses a recent anti-aging study failure, a new obesity startup, and includes a light-hearted conversation on New Year’s resolutions.
Transcript
Play full episode